ProCE Banner Activity

What You Need to Know About the Use of Neoadjuvant Cemiplimab in Advanced cSCC

Clinical Thought

In this expert commentary, read about recent clinical trial data showing beneficial outcomes of neoadjuvant cemiplimab in patients with advanced cutaneous squamous cell carcinoma.

Released: April 13, 2023

Share

Faculty

Crystal Aguh

Crystal Aguh, MD

Associate Professor
Department of Dermatology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc

Faculty Disclosure

Primary Author

Crystal Aguh, MD

Associate Professor
Department of Dermatology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Crystal Aguh, MD: consultant/advisor/speaker: Lilly, Myovant Sciences, Pfizer.